Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04892173
Title NBTXR3 With or Without Cetuximab in LA-HNSCC
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Nanobiotix
Indications
Therapies
Age Groups: senior
Covered Countries USA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.